NDC codes

409238 NDC codes with hospital pricing data in the network.

• NDC 51079-0442-01 — LEVOTHYROXINE SODIUM 100 MCG PO TABS (92 hospitals, 1,569–1,740 samples)
• NDC 51672-4130-01 — LAMOTRIGINE 25 MG TABLET (44 hospitals, 1,569–1,740 samples)
• NDC 53746-0711-01 — GUANFACINE HCL 1 MG PO TABS (34 hospitals, 1,569–1,740 samples)
• NDC 59651-0332-01 — FLUCYTOSINE 500 MG CAPSULE (102 hospitals, 1,569–1,740 samples)
• NDC 60687-0675-11 — HYDROXYZINE HCL 25 MG TABLET (82 hospitals, 1,569–1,740 samples)
• NDC 60687-0710-11 — GUANFACINE 1 MG TABLET (20 hospitals, 1,569–1,740 samples)
• NDC 60687-0710-21 — GUANFACINE HCL 1 MG PO TAB (27 hospitals, 1,569–1,740 samples)
• NDC 64950-0354-55 — OXYCODONE 5 MG/5 ML ORAL SOLN (48 hospitals, 1,569–1,740 samples)
• NDC 65862-0177-60 — CEFDINIR 300 MG CAPSULE (78 hospitals, 1,569–1,740 samples)
• NDC 68084-0300-11 — DANTROLENE SODIUM 25 MG PO CAPS (96 hospitals, 1,569–1,740 samples)
• NDC 68084-0310-01 — DIVALPOEX ER 250MG TAB (79 hospitals, 1,569–1,740 samples)
• NDC 68094-0065-59 — GUANFACINE HCL 1 MG PO TABS (23 hospitals, 1,569–1,740 samples)
• NDC 68094-0065-62 — GUANFACINE 1 MG ORAL TAB (27 hospitals, 1,569–1,740 samples)
• NDC 70954-0240-10 — CARBAMAZEPINE 100 MG/5 ML ORAL SUSPENSION (67 hospitals, 1,569–1,740 samples)
• NDC 00121-0873-32 — LACTULOSE 10 GRAM/15 ML ORAL SOLUTION (28 hospitals, 1,569–1,740 samples)
• NDC 00121-0948-16 — POTASSIUM CHLORIDE 20 MEQ/15 ML ORAL LIQUID (21 hospitals, 1,569–1,740 samples)
• NDC 00904-3854-61 — CARBAMAZEPINE 100 MG CHEWABLE TABLET (137 hospitals, 1,569–1,740 samples)
• NDC 51079-0440-20 — LEVOTHYROXINE 50 MCG ORAL TAB (74 hospitals, 1,569–1,740 samples)
• NDC 62332-0098-31 — ARIPIPRAZOLE 5 MG TABLET (51 hospitals, 1,569–1,740 samples)
• NDC 27241-0115-01 — DIVALPROEX 125 MG CAPSULE DELAYED RELEASE SPRINKLE (48 hospitals, 1,569–1,740 samples)
• NDC 45963-0439-63 — LACTULOSE 240ML SYRP (26 hospitals, 1,569–1,740 samples)
• NDC 47781-0384-26 — OSELTAMIVIR PHOSPHATE 6 MG/ML PO SUSR (75 hospitals, 1,569–1,740 samples)
• NDC 51079-0440-01 — LEVOTHYROXINE 50 MCG TABLET (82 hospitals, 1,569–1,740 samples)
• NDC 51079-0444-20 — LEVOTHYROXINE 25 MCG TABLET (94 hospitals, 1,569–1,740 samples)
• NDC 51672-4041-01 — CARBAMAZEPINE 100 MG CHEWABLE TABLET (64 hospitals, 1,569–1,740 samples)
• NDC 52536-0180-03 — ERYTHROMYCIN 250 MG TABLET,DELAYED RELEASE (80 hospitals, 1,569–1,740 samples)
• NDC 60432-0621-16 — VALPROIC ACID SYRUP (21 hospitals, 1,569–1,740 samples)
• NDC 60687-0157-11 — ARIPIPRAZOLE 2 MG TABLET (66 hospitals, 1,569–1,740 samples)
• NDC 60687-0157-21 — ARIPIPRAZOLE 2 MG PO TABS (60 hospitals, 1,569–1,740 samples)
• NDC 60687-0168-11 — ARIPIPRAZOLE 5 MG PO TABS (61 hospitals, 1,569–1,740 samples)
• NDC 60687-0326-95 — ATOMOXETINE 40 MG CAPSULE (37 hospitals, 1,569–1,740 samples)
• NDC 60687-0699-21 — CEFDINIR 300 MG CAPSULE (49 hospitals, 1,569–1,740 samples)
• NDC 62332-0097-30 — ARIPIPRAZOLE 2 MG TABLET (67 hospitals, 1,569–1,740 samples)
• NDC 62332-0098-30 — ARIPIPRAZOLE 5 MG PO TABS (72 hospitals, 1,569–1,740 samples)
• NDC 62756-0797-88 — DIVALPROEX 250 MG TABLET,DELAYED RELEASE (75 hospitals, 1,569–1,740 samples)
• NDC 65162-0711-10 — GUANFACINE 1 MG TABLET (77 hospitals, 1,569–1,740 samples)
• NDC 65862-0595-01 — DIVALPROEX ER 500 MG TABLET,EXTENDED RELEASE 24 HR (35 hospitals, 1,569–1,740 samples)
• NDC 68084-0157-01 — MORPHINE ER 15 MG TABLETEXTENDED RELEASE (92 hospitals, 1,569–1,740 samples)
• NDC 68084-0157-11 — MORPHINE ER 15 MG TABLET,EXTENDED RELEASE (65 hospitals, 1,569–1,740 samples)
• NDC 68084-0310-11 — DIVALPROEX SODIUM ER 250 MG PO TB24 (44 hospitals, 1,569–1,740 samples)
• NDC 68084-0479-01 — CALCIUM ACETATE(PHOSPHATE BINDERS) 667 MG CAPSULE (80 hospitals, 1,569–1,740 samples)
• NDC 68084-0996-11 — PRAZOSIN 1 MG CAPSULE (66 hospitals, 1,569–1,740 samples)
• NDC 68382-0106-01 — DIVALPROEX 125 MG CAPSULE DELAYED RELEASE SPRINKLE (60 hospitals, 1,569–1,740 samples)
• NDC 69238-1273-06 — OSELTAMIVIR PHOSPHATE 6 MG/ML PO SUSR (25 hospitals, 1,569–1,740 samples)
• NDC 69238-1459-02 — POTASSIUM CHLORIDE 20 MEQ/15 ML ORAL LIQUID (36 hospitals, 1,569–1,740 samples)
• NDC 69339-0148-01 — SUCRALFATE 100 MG/ML ORAL SUSPENSION (10 hospitals, 1,569–1,740 samples)
• NDC 00004-0822-05 — OSELTAMIVIR 6 MG/ML ORAL SUSR (120 hospitals, 1,569–1,740 samples)
• NDC 00071-2012-47 — GABAPENTIN 250 MG/5 ML ORAL SOLUTION (15 hospitals, 1,569–1,740 samples)
• NDC 00074-6624-19 — LEVOTHYROXINE 100 MCG TABLET (18 hospitals, 1,569–1,740 samples)
• NDC 00074-6624-90 — LEVOTHYROXINE 100 MCG ORAL TAB (28 hospitals, 1,569–1,740 samples)